One decade ago, RUNX2 and MYC were shown to collaborate in order to generate T-cell lymphoma in a CD2 promoter-dependent manner in mice because RUNX2 suppressed MYC-dependent apoptosis in lymphoma cells in vivo33. Here, MYC is linked to T-cell non-Hodgkin lymphoma.